Search Content | UT Health San Antonio MD Anderson Cancer Center

Search Result for "*:*"

Research & Publications

Dose–volume correlates of the prevalence of patient-reported trismus in long-term survivorship after oropharyngeal IMRT: A cross-sectional dosimetric analysis

provider

Travis Forney, PA-C, MPAS, BSN Hematology-Oncology

Research & Publications

Platinum Doublet plus Atezolizumab as First-line Treatment in Metastatic Large Cell Neuroendocrine Carcinoma: A Single Institution Experience

Research & Publications

Aphase1a/ 1bfirst-in-human, open-label, dose-escalation, safety, pharmacokinetic, and pharmacodynamic study of oral TP-0903, a potent inhibitor of AXL kinase, administered daily for 21 days to patients with advanced solid tumors.

Research & Publications

The Role of Genetics in sporadic GEP-NETs: A Comprehensive Review of the Literature

Research & Publications

Aphase1a/ 1bfirst-in-human, open-label, dose-escalation, safety, pharmacokinetic, and pharmacodynamic study of oral TP-0903, a potent inhibitor of AXL kinase, administered daily for 21 days to patients with advanced solid tumors.

About the Team

Contact Us

provider

Sahar Heydari, MPAS, PA-C Hematology-Oncology, Physician Assistant

Research & Publications

Ex vivo drug testing of patient-derived lung organoids to predict treatment responses for personalized medicine.